To determine whether CGRP or SP are involved in ET-induced edema, we utilized BIBN 4096, a small molecule antagonist of the CGRP receptor RAMP1, and Spantide I, a peptide antagonist of the SP receptor NK1R. This evidence concerns the gene TFF2 and essential thrombocythemia.